Brief: Kane Biotech announces end of joint development agreement
11/07/2016 22:29
July 11 (Reuters) - Kane Biotech Inc KNE.V :
* Kane biotech announces end of joint development agreement
and appointment of vice-president sales
* Kane biotech will be paid $50,000 which will be included
in corporation's Q2 financial statements
* Global Animal Health Co with which it had joint
development agreement made business decision to decline option
to commercialize companion pet oral care technology
Source text for Eikon: urn:newsml:reuters.com:*:nCCN8VpCfc
Further company coverage: KNE.V
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update